CRISPR Therapeutics
CRSP
#3013
Rank
HK$43.36 B
Marketcap
HK$451.84
Share price
-0.52%
Change (1 day)
53.97%
Change (1 year)

Annual Reports (10-K)

Latest form 10-K annual reports for CRISPR Therapeutics CIK: 0001674416

Thumbnail CRISPR Therapeutics 10-K Annual Report 2025

10-K Annual Report 2025

Language: English

View Annual Report (10-K)
Thumbnail CRISPR Therapeutics 10-K Annual Report 2024

10-K Annual Report 2024

Language: English

View Annual Report (10-K)
Thumbnail CRISPR Therapeutics 10-K Annual Report 2023

10-K Annual Report 2023

Language: English

View Annual Report (10-K)
Thumbnail CRISPR Therapeutics 10-K Annual Report 2022

10-K Annual Report 2022

Language: English

View Annual Report (10-K)
Thumbnail CRISPR Therapeutics 10-K Annual Report 2021

10-K Annual Report 2021

Language: English

View Annual Report (10-K)
Thumbnail CRISPR Therapeutics 10-K Annual Report 2020

10-K Annual Report 2020

Language: English

View Annual Report (10-K)
Thumbnail CRISPR Therapeutics 10-K Annual Report 2019

10-K Annual Report 2019

Language: English

View Annual Report (10-K)
Thumbnail CRISPR Therapeutics 10-K Annual Report 2018

10-K Annual Report 2018

Language: English

View Annual Report (10-K)
Thumbnail CRISPR Therapeutics 10-K Annual Report 2017

10-K Annual Report 2017

Language: English

View Annual Report (10-K)
Thumbnail CRISPR Therapeutics 10-K Annual Report 2016

10-K Annual Report 2016

Language: English

View Annual Report (10-K)